Next-Generation 3D Scaffolds for Nano-Based Chemotherapeutics Delivery and Cancer Treatment

Author:

Shahriar S. M. Shatil,Andrabi Syed Muntazir,Islam Farhana,An Jeong ManORCID,Schindler Samantha J.,Matis Mitchell P.,Lee Dong YunORCID,Lee Yong-kyu

Abstract

Cancer is the leading cause of death after cardiovascular disease. Despite significant advances in cancer research over the past few decades, it is almost impossible to cure end-stage cancer patients and bring them to remission. Adverse effects of chemotherapy are mainly caused by the accumulation of chemotherapeutic agents in normal tissues, and drug resistance hinders the potential therapeutic effects and curing of this disease. New drug formulations need to be developed to overcome these problems and increase the therapeutic index of chemotherapeutics. As a chemotherapeutic delivery platform, three-dimensional (3D) scaffolds are an up-and-coming option because they can respond to biological factors, modify their properties accordingly, and promote site-specific chemotherapeutic deliveries in a sustainable and controlled release manner. This review paper focuses on the features and applications of the variety of 3D scaffold-based nano-delivery systems that could be used to improve local cancer therapy by selectively delivering chemotherapeutics to the target sites in future.

Funder

National Research Foundation of Korea

Publisher

MDPI AG

Subject

Pharmaceutical Science

Reference185 articles.

1. Herbal medicine as inducers of apoptosis in cancer treatment;Safarzadeh;Adv. Pharm. Bull.,2014

2. Controlled drug delivery vehicles for cancer treatment and their performance;Senapati;Signal Transduct. Target. Ther.,2018

3. Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2020

4. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment;Schirrmacher;Int. J. Oncol.,2019

5. Toxicity of chemotherapy;Lowenthal;Hematol./Oncol. Clin.,1996

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3